Search

Your search keyword '"Schreiber, Stefan"' showing total 4,419 results

Search Constraints

Start Over You searched for: Author "Schreiber, Stefan" Remove constraint Author: "Schreiber, Stefan"
4,419 results on '"Schreiber, Stefan"'

Search Results

5. Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS‑CoV‑2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort

7. Selection of cross-reactive T cells by commensal and food-derived yeasts drives cytotoxic TH1 cell responses in Crohn’s disease

11. Depression and fatigue six months post-COVID-19 disease are associated with overlapping symptom constellations: A prospective, multi-center, population-based cohort study

12. Effects of lifestyle and associated diseases on serum CC16 suggest complex interactions among metabolism, heart and lungs

13. Tryptophan degradation as a systems phenomenon in inflammation – an analysis across 13 chronic inflammatory diseases

14. Serine metabolism is crucial for cGAS-STING signaling and viral defense control in the gut

15. Predictors of non-recovery from fatigue and cognitive deficits after COVID-19: a prospective, longitudinal, population-based study

17. Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY)

18. Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn’s Disease Regardless of Prior Biologic Exposure

19. Transethnic analysis of the human leukocyte antigen region for ulcerative colitis reveals not only shared but also ethnicity-specific disease associations.

20. Dynamic changes in extracellular vesicle-associated miRNAs elicited by ultrasound in inflammatory bowel disease patients

21. FixNCut: single-cell genomics through reversible tissue fixation and dissociation

22. HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis

23. THU-254-YI Differential gene expression profiles of liver tissue, subcutaneous and visceral adipose tissue delineates severity of MASLD in heavily obese patients

25. Cohort profile: the Food Chain Plus (FoCus) cohort

27. Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility

28. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies

30. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics

36. Single-cell RNA sequencing of nasal mucosa for molecular and genetic analysis of chemosensory dysfunction in post-COVID patients

37. Efficacy and Safety of Etrasimod in Patients with Moderately to Severely Active Isolated Proctitis: Results From the Phase 3 ELEVATE UC Clinical Programme

38. Changes of Periodontal Parameters and Microbiome Composition of Tooth Pocket in Patients with Chronic Inflammatory Diseases Receiving Targeted Anti-Cytokine Therapy

39. Correspondence

40. Dynamic Changes in Extracellular Vesicle-Associated miRNAs Elicited by Ultrasound in Inflammatory Bowel Disease Patients

41. Contrast-Enhanced Endoscopic Ultrasound Detects Early Therapy Response Following Anti-TNF Therapy in Patients with Ulcerative Colitis

42. Inflammatory bowel disease (IBD) patients with impaired quality of life on biologic therapy benefit from the support of an IBD nurse specialist: Results of a randomised controlled trial in Germany (IBDBIO‐ASSIST study)

43. Longitudinal multi-omics analysis identifies early blood-based predictors of anti-TNF therapy response in inflammatory bowel disease

44. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity

45. DNA methyltransferase 3A controls intestinal epithelial barrier function and regeneration in the colon

46. Statistical biases due to anonymization evaluated in an open clinical dataset from COVID-19 patients

47. Cross-tissue transcriptome-wide association studies identify susceptibility genes shared between schizophrenia and inflammatory bowel disease

48. Fatigue and cognitive impairment after COVID-19: A prospective multicentre study

50. IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus

Catalog

Books, media, physical & digital resources